Glenmark’s Unique R&D Strategy

This case study is based on our video interview of Glenn Saldanha, Co-founder, Chairman and Managing Director, Glenmark Pharmaceutical Ltd


Glenmark ranks as one of the top ten companies with a turnover between $200 million to $1 billion. Gracious Saldanha started Glenmark in a very small way in 1977. In 1998, Glenn Saldanha son of Gracious Saldanha took over the helms of the organization and steered the company on an uncharted course. His basic aim was to concentrate on Research and Development in the two lines of business namely Speciality Business i.e. Drug Discovery and Speciality Business i.e. Formulation Business. The third area was the Generics area. Glenn Saldanha also set up manufacturing ...

Get Cases in Corporate Strategy now with O’Reilly online learning.

O’Reilly members experience live online training, plus books, videos, and digital content from 200+ publishers.